TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36028878

Group type: EXPERIMENTAL
Intervention: Rosemary cream
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 34545545

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (gemcitabine and cisplatin) for 6 cycles
Number of subjects: 50

Group type: COMPARATOR
Intervention: Surveillance alone (control group)
Number of subjects: 50
Study: 32011378

Group type: EXPERIMENTAL
Intervention: Antimicrobial drape
Number of subjects: 1659

Group type: COMPARATOR
Intervention: No antimicrobial drape (Control)
Number of subjects: 1659
Study: 32049215

Group type: EXPERIMENTAL
Intervention: Creation of four concept maps
Number of subjects: 77
Study: 35881301

Group type: EXPERIMENTAL
Intervention: Simultaneous exercise and cognitive training
Number of subjects: 35

Group type: COMPARATOR
Intervention: Exercise training
Number of subjects: 35

Group type: COMPARATOR
Intervention: Cognitive training
Number of subjects: 35
Study: 33605025

Group type: EXPERIMENTAL
Intervention: Eyebrow tattooing (ET)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Non-eyebrow tattooing (NET)
Number of subjects: 28
Study: 34711947

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus carboplatin plus paclitaxel (ACP)
Number of subjects: 1202

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus bevacizumab plus carboplatin plus paclitaxel (ABCP)
Number of subjects: 1202

Group type: COMPARATOR
Intervention: Bevacizumab plus carboplatin plus paclitaxel (BCP)
Number of subjects: 1202

Group type: COMPARATOR
Intervention: Comparison of atezolizumab arms (ACP plus ABCP) vs BCP
Number of subjects: 1202

Group type: COMPARATOR
Intervention: Comparison of ABCP vs BCP
Number of subjects: 1202
Study: 34021888

Group type: EXPERIMENTAL
Intervention: Serratus anterior block + general anesthesia + patient‐controlled serratus anterior plane block (PCSAPB group)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Serratus anterior block + general anesthesia + patient‐controlled intravenous analgesia (PCIA group)
Number of subjects: 84

Group type: COMPARATOR
Intervention: General anesthesia + PCIA (control group)
Number of subjects: 84
Study: 32345788

Group type: EXPERIMENTAL
Intervention: CEE + MPA therapy
Number of subjects: 27347

Group type: EXPERIMENTAL
Intervention: CEE-alone therapy
Number of subjects: 27347

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27347

Group type: EXPERIMENTAL
Intervention: Estrogen hormone therapy (HT)
Number of subjects: 27347
Study: 35360984

Group type: EXPERIMENTAL
Intervention: Cannula group (short peripheral intravenous cannula with straight-tip guide-wire)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Needle group (needle with J-tip guide-wire)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Cannula group
Number of subjects: 130

Group type: COMPARATOR
Intervention: Needle group
Number of subjects: 130
Study: 33094728

Group type: EXPERIMENTAL
Intervention: Empagliflozin (EMPA) 25 mg/day for 24 weeks
Number of subjects: 57
Study: 32493872

Group type: EXPERIMENTAL
Intervention: Music therapy (30 minutes daily for 6 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment with 30 minutes of quiet rest (control)
Number of subjects: 0
Study: 35113605

Group type: EXPERIMENTAL
Intervention: Community-based organizations and community clinics screening for mental health
Number of subjects: 1057

Group type: COMPARATOR
Intervention: Compared to non-Latinx Whites
Number of subjects: 1057
Study: 34640575

Group type: EXPERIMENTAL
Intervention: Muscle training (volitional protrusion against resistance)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham group (negligible resistance)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Muscle training
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 68
Study: 35048627

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg tablets one time per day for 7 days
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (no diazepam)
Number of subjects: 89
Study: 33984786

Group type: EXPERIMENTAL
Intervention: L-arginine supplementation
Number of subjects: 118

Group type: COMPARATOR
Intervention: Short-term personal exposure to air pollutants
Number of subjects: 118
Study: 33031185

Group type: EXPERIMENTAL
Intervention: Combined trabeculotomy-trabeculectomy (CTT) with mitomycin-C (MMC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin-C (MMC)
Number of subjects: 30
Study: 32357081

Group type: EXPERIMENTAL
Intervention: Serum cortisol:cortisone ratio
Number of subjects: 269
Study: 36282607

Group type: EXPERIMENTAL
Intervention: Ketone supplement (7 g of beta-hydroxybutyrate, total of 14 g/d)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 33031169

Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure monitoring (ABPM)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Office blood pressure monitoring
Number of subjects: 146
Study: 33095526

Group type: EXPERIMENTAL
Intervention: Intramuscular dexamethasone
Number of subjects: 2852

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2852
Study: 35210264

Group type: EXPERIMENTAL
Intervention: Tocilizumab (162 mg per week)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 33186516

Group type: EXPERIMENTAL
Intervention: SF2a‐TT15 vaccine candidate (2 μg dose)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: SF2a‐TT15 vaccine candidate (10 μg dose)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: SF2a‐TT15 vaccine candidate (2 μg dose, adjuvanted with alum)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: SF2a‐TT15 vaccine candidate (adjuvanted and non-adjuvanted)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: SF2a‐TT15 vaccine candidate
Number of subjects: 64
Study: 36411694

Group type: EXPERIMENTAL
Intervention: Chinese version of Critical Cultural Competence Scale (CCCS)
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Exploratory factor analysis
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Confirmatory factor analysis
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Reliability measures
Number of subjects: 580
Study: 32075842

Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygenation (HFNO)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Standard oxygen therapy (SOT)
Number of subjects: 380
Study: 35668472

Group type: COMPARATOR
Intervention: ECD intervention (individually and combined with IHIP)
Number of subjects: 317

Group type: COMPARATOR
Intervention: IHIP intervention (individually and combined with ECD)
Number of subjects: 317
Study: 33618403

Group type: EXPERIMENTAL
Intervention: CT scan planning (group 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard three degrees adjustment (group 2)
Number of subjects: 50
Study: 33210382

Group type: EXPERIMENTAL
Intervention: NUC-1031 625 mg/m2 and cisplatin 25 mg/m2
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: NUC-1031 725 mg/m2 and cisplatin 25 mg/m2
Number of subjects: 21
Study: 36272450

Group type: EXPERIMENTAL
Intervention: Impella CP
Number of subjects: 0
Study: 33253427

Group type: EXPERIMENTAL
Intervention: Desflurane-remifentanil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sevoflurane-fentanyl
Number of subjects: 60
Study: 32732643

Group type: EXPERIMENTAL
Intervention: Text message intervention promoting help-seeking behaviors for 3 months
Number of subjects: 45
Study: 36342237

Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution (ANH)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: ANH
Number of subjects: 197

Group type: COMPARATOR
Intervention: ANH and Standard treatment
Number of subjects: 197
Study: 33048421

Group type: EXPERIMENTAL
Intervention: Tasmannia lanceolata extract (TLE)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 32329438

Group type: EXPERIMENTAL
Intervention: mHealth technology and behavioral messages tailored to Patient Activation Measure (PAM) level at baseline
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (received equipment but not messaging)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 240
Study: 35970940

Group type: EXPERIMENTAL
Intervention: Lovastatin (60 mg/day for 3 days)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 33805501

Group type: EXPERIMENTAL
Intervention: Participatory intervention to improve the psychosocial work environment and mental health.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract).
Number of subjects: 0
Study: 35229621

Group type: EXPERIMENTAL
Intervention: Structured lifestyle modification intervention delivered by frontline health workers
Number of subjects: 12313

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 12313
Study: 34117699

Group type: EXPERIMENTAL
Intervention: Corneal crosslinking (CXL)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (untreated eye)
Number of subjects: 38
Study: 35325627

Group type: EXPERIMENTAL
Intervention: 12-month group-based multimodal physical activity programme (64 1-hour exercise sessions) and behavioural maintenance (21 45-minute sessions)
Number of subjects: 777

Group type: COMPARATOR
Intervention: Brief advice (three healthy ageing education sessions)
Number of subjects: 777
Study: 32968038

Group type: EXPERIMENTAL
Intervention: Technical modifications of the workstand
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Education based on practical training
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Behavioural training
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 18
Study: 35459802

Group type: EXPERIMENTAL
Intervention: FAEV
Number of subjects: 94

Group type: COMPARATOR
Intervention: EMA/CO
Number of subjects: 94
Study: 33788439

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Shaoshang (LU11) 30 minutes before anesthesia, and EA at Chize (LU5) and Hegu (LI4) during surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no electroacupuncture)
Number of subjects: 60
Study: 34476476

Group type: EXPERIMENTAL
Intervention: Trial 2 Arm C
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Trial 1 Arm B
Number of subjects: 418

Group type: COMPARATOR
Intervention: Eurocran dental index
Number of subjects: 418

Group type: COMPARATOR
Intervention: 5YO index
Number of subjects: 418

Group type: COMPARATOR
Intervention: GOSLON Yardstick
Number of subjects: 418

Group type: COMPARATOR
Intervention: Orthodontic treatment
Number of subjects: 418
Study: 35922101

Group type: EXPERIMENTAL
Intervention: Single 120-minute session of electronic Screening and Brief Intervention (SBI) for alcohol use in pregnancy.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single session plus two 5-minute boosters of electronic SBI.
Number of subjects: 0

Group type: COMPARATOR
Intervention: None (no brief intervention).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tailored text messaging (none vs twice weekly messages).
Number of subjects: 0
Study: 33012243

Group type: EXPERIMENTAL
Intervention: One-time hope intervention
Number of subjects: 292

Group type: COMPARATOR
Intervention: Attention-matched progressive muscle relaxation intervention
Number of subjects: 292
Study: 32176107

Group type: EXPERIMENTAL
Intervention: Continuous nursing care based on the Information, Knowledge, Attitude, and Practice (IKAP) theory
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard nursing care (Control)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Continuous nursing care based on the IKAP theory
Number of subjects: 70
Study: 34918330

Group type: EXPERIMENTAL
Intervention: LGA infants
Number of subjects: 336

Group type: COMPARATOR
Intervention: AGA infants
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Early solid feeding (<6 months)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Delayed solid feeding (≥6 months)
Number of subjects: 336
Study: 35900355

Group type: EXPERIMENTAL
Intervention: Application explaining low GPA due to a mental health condition
Number of subjects: 99

Group type: COMPARATOR
Intervention: Application explaining low GPA due to a physical health condition
Number of subjects: 99

Group type: COMPARATOR
Intervention: Application with no explanation for low GPA
Number of subjects: 99
Study: 34481498

Group type: EXPERIMENTAL
Intervention: Empagliflozin and Linagliptin (E+L group)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Metformin and Insulin Glargine (M+I group)
Number of subjects: 97
Study: 33332234

Group type: EXPERIMENTAL
Intervention: Infrared PBM group (IPG)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Red PBM group (RPG)
Number of subjects: 32
Study: 36126199

Group type: EXPERIMENTAL
Intervention: Taping
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 31
Study: 32029163

Group type: EXPERIMENTAL
Intervention: Photostimulation at 16 weeks (PS16)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Photostimulation at 18 weeks (PS18)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Photostimulation at 20 weeks (PS20)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Photostimulation at 22 weeks (PS22)
Number of subjects: 192
Study: 35997273

Group type: EXPERIMENTAL
Intervention: Dynamic stepwise PEEP strategy (DynPEEP) with 20 cmH2O maximum PEEP
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Dynamic stepwise PEEP strategy (DynPEEP) with 14 cmH2O maximum PEEP
Number of subjects: 65

Group type: COMPARATOR
Intervention: Positive pressure ventilation (PPV) at 8 cmH2O PEEP
Number of subjects: 65
Study: 36064876

Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate (LC)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Calcium carbonate (CC)
Number of subjects: 239
Study: 33043684

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy for Body Image (IPT‐BI)
Number of subjects: 18
Study: 35541985

Group type: EXPERIMENTAL
Intervention: Pranayama intervention (twice daily for 28 days)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group (normal daily routine, no pranayama)
Number of subjects: 250
Study: 34489271

Group type: EXPERIMENTAL
Intervention: Speech and language therapy plus scalp acupuncture
Number of subjects: 203

Group type: COMPARATOR
Intervention: Speech and language therapy alone
Number of subjects: 203
Study: 32502040

Group type: EXPERIMENTAL
Intervention: Tuna-Hui-Chun-Gong (TNHCG) exercises
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard COPD drugs
Number of subjects: 120
Study: 33800392

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 infection assessment via PCR
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Specific IgG assessment via ELISA
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Assessment of individual behavior and institutional infection prevention measures
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Adherence to infection prevention measures
Number of subjects: 535
Study: 35329869

Group type: EXPERIMENTAL
Intervention: Iloprost inhalation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (saline inhalation)
Number of subjects: 40
Study: 32690737

Group type: EXPERIMENTAL
Intervention: Ayushman Bharat ‐ Pradhan Mantri Jan Arogya Yojana (AB ‐ PMJAY)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Public and private hospitals
Number of subjects: 92
Study: 35045350

Group type: EXPERIMENTAL
Intervention: ALA-PDT
Number of subjects: 82
Study: 33870587

Group type: EXPERIMENTAL
Intervention: IAN collagen‐membrane wrapping and interposing bone graft to overlay 23 implants
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional IANL in direct contact with 20 implants
Number of subjects: 18
Study: 36108662

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg administered intravenously every 3 weeks for up to 18 cycles
Number of subjects: 1177

Group type: COMPARATOR
Intervention: Placebo administered intravenously every 3 weeks for up to 18 cycles
Number of subjects: 1177

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg
Number of subjects: 1177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1177
Study: 34077831

Group type: EXPERIMENTAL
Intervention: High-dose mycophenolate mofetil (≥ 2000 mg/day)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Low-dose mycophenolate mofetil (< 1000 mg/day)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Moderate-dose mycophenolate mofetil (1000 mg/day ≤ MMF dose < 2000 mg/day)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Patients with autoimmune diseases
Number of subjects: 62
Study: 33398861

Group type: EXPERIMENTAL
Intervention: Buzzy device (experimental group)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no Buzzy device)
Number of subjects: 56
Study: 34871375

Group type: EXPERIMENTAL
Intervention: Tricuspid valve percutaneous repair strategy using a clip dedicated to the tricuspid valve
Number of subjects: 300

Group type: COMPARATOR
Intervention: Best guideline-directed medical therapy
Number of subjects: 300
Study: 34388107

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 65
Study: 32859887

Group type: EXPERIMENTAL
Intervention: Palliative primary tumor resection
Number of subjects: 0

Group type: COMPARATOR
Intervention: No surgical resection of the primary tumor
Number of subjects: 0
Study: 35441706

Group type: EXPERIMENTAL
Intervention: Triheptanoin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 33593938

Group type: EXPERIMENTAL
Intervention: Intervention group (congressional offices)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention group (researchers)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (congressional offices)
Number of subjects: 0
Study: 32047013

Group type: EXPERIMENTAL
Intervention: Gamma3 nail (Stryker; proximally dynamic)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Trigen Intertan nail (Smith & Nephew) in a dynamic lag screw configuration
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Trigen Intertan nail (Smith & Nephew) in a static lag screw configuration
Number of subjects: 900

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 900
Study: 35132582

Group type: EXPERIMENTAL
Intervention: Randomized marker method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multiple imputation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Complete datasets
Number of subjects: 0
Study: 35868416

Group type: EXPERIMENTAL
Intervention: Moderate pushing
Number of subjects: 1710

Group type: COMPARATOR
Intervention: Intensive pushing
Number of subjects: 1710
Study: 33446608

Group type: EXPERIMENTAL
Intervention: Oral dexamethasone (6 mg once daily for 4 days)
Number of subjects: 401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Oral dexamethasone
Number of subjects: 401
Study: 32827290

Group type: EXPERIMENTAL
Intervention: NORTH STAR
Number of subjects: 24
Study: 34921663

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with Butorphanol (1 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 60
Study: 33032657

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 35760812

Group type: EXPERIMENTAL
Intervention: Heterologous booster of NVSI‐06‐08
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Homologous booster of BBIBP‐CorV
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Both interventions (NVSI‐06‐08 and BBIBP‐CorV)
Number of subjects: 1800
Study: 34130748

Group type: EXPERIMENTAL
Intervention: HT-delivered Brief Intervention (BI)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Informative leaflet
Number of subjects: 294
Study: 32401307

Group type: EXPERIMENTAL
Intervention: Human milk oligosaccharides (HMOs)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Factor 3 in colostrum
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Fucosyl‐disialyllacto‐N‐hexose (FDSLNH)
Number of subjects: 153
Study: 33130213

Group type: EXPERIMENTAL
Intervention: Clinical Frailty Scale (CFS) in patients aged 65 years or older
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Age, chronic kidney disease, and previous stroke
Number of subjects: 255

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 255
Study: 33261645

Group type: EXPERIMENTAL
Intervention: Rice protein (24g daily)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Whey protein (24g daily)
Number of subjects: 24
Study: 36141561

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (HI, 85% VO2max, n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Moderate-intensity exercise (MI, 65% VO2max, n = 10)
Number of subjects: 20
Study: 34718233

Group type: EXPERIMENTAL
Intervention: Temporary uterine artery clamping
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 200
Study: 35020685

Group type: EXPERIMENTAL
Intervention: Orofacial treatment (physical therapy and occlusal splints)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Orofacial treatment
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Change in TMD pain
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no other treatment)
Number of subjects: 80
Study: 34351414

Group type: EXPERIMENTAL
Intervention: Aflibercept 2 mg every 16 weeks after 3 initial monthly doses (2q16 group)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Aflibercept 2 mg every 8 weeks after 5 initial monthly doses with PRN dosing (2q8/PRN group)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Combined aflibercept groups
Number of subjects: 402

Group type: COMPARATOR
Intervention: Control group (sham injections)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Aflibercept 2 mg every 16 weeks (2q16 group)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Aflibercept 2 mg every 8 weeks with PRN dosing (2q8/PRN group)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Aflibercept 2q16 group
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Aflibercept 2q8/PRN group
Number of subjects: 402
Study: 34727737

Group type: EXPERIMENTAL
Intervention: Endovascular therapy
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control
Number of subjects: 161